Medicine and Dentistry
Multidrug Resistance
100%
ABC Transporter
82%
Gene
81%
Cells
57%
ABC Transporter Subfamily B
51%
Patient
50%
Therapeutic Procedure
44%
Chemotherapy
44%
Drug
43%
Chemotherapeutic Agent
43%
Acute Myeloid Leukemia
32%
DNA Microarray
32%
Cancer Cell Line
32%
Drug Resistance
32%
Effusion
32%
Overall Survival
30%
In Vitro
29%
Anticarcinogen
25%
Diagnosis
24%
Gene Expression Profiling
24%
Gene Expression
23%
Analysis
21%
Malignant Neoplasm
21%
Doxorubicin
20%
Cisplatin
19%
Inpatient
19%
Paclitaxel
19%
Serous Carcinoma
16%
Melanogenesis
16%
Cancer Stem Cell
16%
Differential Diagnosis
16%
Ovarian Cancer Cell Line
16%
Sarcoma Cell
16%
Induced Resistance
16%
Hepatocellular Carcinoma
16%
Nodular Melanoma
16%
B Cell
16%
Non-Hodgkin Lymphoma
16%
Microarray
16%
Childhood
16%
Mitogen-Activated Protein Kinase
16%
Histone Deacetylase Inhibitor
16%
Romidepsin
16%
MEK Inhibitor
16%
Human Immunodeficiency Virus Proteinase Inhibitor
16%
Kaposi Sarcoma
16%
Quantitative Analysis
16%
Cancer Chemotherapy
16%
Neoplasm
16%
Flavanone Derivative
16%
Biochemistry, Genetics and Molecular Biology
Multidrug Resistance
95%
ABC Transporter
87%
Cancer Cell
82%
P-Glycoprotein
69%
Development
50%
Nested Gene
48%
Drug Resistance
42%
Nucleotide
35%
Binding Domain
35%
Cisplatin
32%
Transporter Genes
30%
Sample
26%
ABCB5
21%
Drug Binding
20%
ABCG2
19%
Doxorubicin
18%
Data Base
17%
Repressor
16%
ABCB11
16%
Videorecording
16%
CD44
16%
Cancer Stem Cell
16%
ABCC4
16%
Interpersonal Communication
16%
Modulation
16%
ABCA3
16%
Mouse
16%
Mutant
16%
Melanogenesis
16%
Childhood
16%
Gene Therapy
16%
Induced Resistance
16%
Drug Metabolism
16%
Haloperidol
16%
Quantitative Technique
16%
Allele
16%
Glutathione
15%
Solute
14%
CD24
14%
Protein
13%
Drug Binding Site
13%
Gene Expression
11%
Mutation
11%
Adenosine Triphosphate
10%
Computer Model
10%
ATPase
10%
RNA Interference
10%
Survival
9%
Signal Transduction
9%
Comprehension
9%
Pharmacology, Toxicology and Pharmaceutical Science
Malignant Neoplasm
79%
Drug Resistance
49%
Drug
42%
Neoplasm
33%
Effusion
30%
Chemotherapy
28%
Multiple Drug Resistance
26%
Diseases
16%
Human Immunodeficiency Virus Proteinase Inhibitor
16%
Kaposi Sarcoma
16%
DNA
16%
Flavanone
16%
Cancer Chemotherapy
16%
Cisplatin
16%
Drug Metabolism
16%
Acute Myeloid Leukemia
16%
Ovary Cancer
16%
Glutathione
13%
Enzyme
10%
Solute Carrier Protein
10%
Adenosine Triphosphate
10%
Antiinfective Agent
8%
Clinical Trial
8%
Protein
7%
P-Glycoprotein
7%
Liver Cancer
5%
Eukaryote
5%
Thioxanthene
5%
Survival
5%
Systemic Pharmacokinetics
5%
Drug-Drug Interaction
5%
Cytochrome P450
5%
Taxane
5%
Multidrug Resistance Associated Protein 1
5%